Most Myeloid Neoplasms With Deletion of Chromosome 16q Are Distinct From Acute Myeloid Leukemia With Inv(16)(p13.1q22): A Bone Marrow Pathology Group Multicenter Study.

Conclusions: Myeloid neoplasms with isolated del(16q) with deletion of the CBFB but lacking CBFB-MYH11 rearrangement should not be considered a variant of the AML-defining inv(16). PMID: 28375434 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/28375434?dopt=Abstract

Source: American Journal of Clinical Pathology - April 1, 2017 Category: Pathology Authors: Rogers HJ, Hsi ED, Tang G, Wang SA, Bueso-Ramos CE, Lubin D, Morrissette JJ, Bagg A, Cherukuri DP, George TI, Peterson L, Liu YC, Mathew S, Orazi A, Hasserjian RP Tags: Am J Clin Pathol Source Type: research

More News: Acute Leukemia | Acute Myeloid Leukemia | Leukemia | Pathology | Study